Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, United States.
Institute for Health Research and Policy, University of Illinois Chicago, Chicago, IL, United States.
JMIR Res Protoc. 2024 May 2;13:e53646. doi: 10.2196/53646.
Ehlers-Danlos syndromes (EDS) are a group of connective tissue disorders caused by fragile lax collagen. Current EDS research lacks racial and ethnic diversity. The lack of diversity may be associated with the complexities of conducting a large international study on an underdiagnosed condition and a lack of EDS health care providers who diagnose and conduct research outside of the United States and Europe. Social media may be the key to recruiting a large diverse EDS sample. However, studies that have used social media to recruit have not been able to recruit diverse samples.
This study aims to discuss challenges, strategies, outcomes, and lessons learned from using social media to recruit a large sample of females with EDS.
Recruitment on social media for a cross-sectional survey examining dyspareunia (painful sexual intercourse) in females was examined. Inclusion criteria were (1) older than 18 years of age, (2) assigned female at birth, and (3) diagnosed with EDS. Recruitment took place on Facebook and Twitter (now X), from June 1 to June 25, 2019.
A total of 1178 females with EDS were recruited from Facebook (n=1174) and X (n=4). On Facebook, participants were recruited via support groups. A total of 166 EDS support groups were identified, 104 permitted the principal investigator to join, 90 approved posting, and the survey was posted in 54 groups. Among them, 30 of the support groups posted in were globally focused and not tied to any specific country or region, 21 were for people in the United States, and 3 were for people outside of the United States. Recruitment materials were posted on X with the hashtag #EDS. A total of 1599 people accessed the survey and 1178 people were eligible and consented. The average age of participants was 38.6 (SD 11.7) years. Participants were predominantly White (n=1063, 93%) and non-Hispanic (n=1046, 92%). Participants were recruited from 29 countries, with 900 (79%) from the United States and 124 (11%) from Great Britain.
Our recruitment method was successful at recruiting a large sample. The sample was predominantly White and from North America and Europe. More research needs to be conducted on how to recruit a diverse sample. Areas to investigate may include connecting with more support groups from outside the United States and Europe, researching which platforms are popular in different countries, and translating study materials into different languages. A larger obstacle to recruiting diverse samples may be the lack of health care providers that diagnose EDS outside the United States and Europe, making the pool of potential participants small. There needs to be more health care providers that diagnose and treat EDS in countries that are predominantly made up of people of color as well as research that specifically focuses on these populations.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/53646.
埃勒斯-当洛斯综合征(EDS)是一组由脆弱松弛的胶原引起的结缔组织疾病。目前的 EDS 研究缺乏种族和民族多样性。缺乏多样性可能与在一个诊断不足的疾病上进行大型国际研究的复杂性以及在美国和欧洲以外诊断和进行研究的 EDS 医疗保健提供者的缺乏有关。社交媒体可能是招募大量不同 EDS 样本的关键。然而,利用社交媒体招募的研究未能招募到多样化的样本。
本研究旨在讨论利用社交媒体招募大量 EDS 女性样本所面临的挑战、策略、结果和经验教训。
对一项关于女性性交痛(疼痛性性交)的横断面调查进行了社交媒体招募。纳入标准为:(1)年龄大于 18 岁,(2)出生时被指定为女性,(3)被诊断为 EDS。招募工作于 2019 年 6 月 1 日至 6 月 25 日在 Facebook 和 Twitter(现 X)上进行。
共从 Facebook(n=1174)和 X(n=4)招募了 1178 名 EDS 女性。在 Facebook 上,参与者通过支持小组招募。共确定了 166 个 EDS 支持小组,其中 104 个允许主要研究者加入,90 个允许发布,调查发布在 54 个小组中。其中,30 个支持小组是全球性的,不与任何特定国家或地区有关,21 个在美国,3 个在国外。在 X 上发布了带有标签#EDS 的招募材料。共有 1599 人访问了该调查,1178 人符合条件并同意参加。参与者的平均年龄为 38.6(SD 11.7)岁。参与者主要为白人(n=1063,93%)和非西班牙裔(n=1046,92%)。参与者来自 29 个国家,其中 900 人(79%)来自美国,124 人(11%)来自英国。
我们的招募方法成功地招募了大量样本。该样本主要为白人和来自北美和欧洲。需要进一步研究如何招募多样化的样本。可研究的领域包括与美国和欧洲以外的更多支持小组建立联系,研究哪些平台在不同国家受欢迎,以及将研究材料翻译成不同的语言。招募多样化样本的一个更大障碍可能是在美国和欧洲以外诊断 EDS 的医疗保健提供者不足,导致潜在参与者人数较少。需要在主要由有色人种组成的国家有更多的医疗保健提供者来诊断和治疗 EDS,以及专门针对这些人群的研究。
国际注册报告标识符(IRRID):RR1-10.2196/53646。